...Business: Diagnostic Date completed: 2014-09-04 Type: Venture financing Raised: EUR15 million ($19.7 million) Investors: RMM; Valiance...

...Biocartis is majority owner of the newco, which raised EUR15 million ($19.7 million) from RMM; Valiance...

...is majority owner of the newco, which raised EUR 15 million ($19.7 million) from RMM; Valiance...

...Idylla approaches commercialization. Existing investors in the E round were RMM; Debiopharm Group ; PMV; Valiance...

...11/5/13 Type: Venture financing Raised: €30 million ($40.5 million) Investors: RMM; Debiopharm Group ; PMV; Valiance...

...million) from existing investors in a series E round. RMM; Debiopharm Group (Lausanne, Switzerland); PMV; Valiance...

...million Investors: Accuitive Medical Ventures; American Equities Overseas; De Novo Ventures; Medicis Capital; Saratoga Ventures; Valiance WIR...

...existing investors Accuitive Medical Ventures; American Equities Overseas; DeNovo Ventures; Medicis Capital; Saratoga Ventures; and Valiance...

...million) Shares: 8.7 million Price: €2.06 Shares after offering: 34.3 million Placement agent: Petercam Investors: Valiance...

...Diagnostic Date completed: 12/12/12 Type: Venture financing Raised: €34.5 million ($44.5 million) Investors: PMV; RMM; Valiance...